To achieve its therapeutic effects in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS, the DMF (and MMF) mediated activation of HCAR2 is required not only to inhibit neutrophil infiltration [47], but also to modulate microglia phenotype [22]. This evidence concerns the gene HCAR2 and myeloid sarcoma.